Angiotensin II type-1 receptor-JAK/STAT pathway mediates the induction of visfatin in angiotensin ii-induced cardiomyocyte hypertrophy

American Journal of the Medical Sciences

Volumn 343, Issue 3, 2012, Pages 220-226

  Chang, Liang ^a,b   Yang, Rong ^a,b   Wang, Mei ^a,b   Liu, Jinming ^a,b   Wang, Yaling ^a,b   Zhang, Hui ^a,b   Li, Yongjun ^a,b  

^a HEBEI MEDICAL UNIVERSITY   (China)

^b Hebei Institute of Cardiovascular and Cerebrovascular Diseases   (China)

Author keywords

Angiotensin II; Hypertrophy; Myocyte; Visfatin

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; 1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN II; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; BRAIN NATRIURETIC PEPTIDE; JANUS KINASE; N BENZYL 2 CYANO 3 (3,4 DIHYDROXYPHENYL)ACRYLAMIDE; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; STAT PROTEIN; TELMISARTAN;

ANIMAL CELL; ARTICLE; CELL VIABILITY; FIBROBLAST; HEART HYPERTROPHY; HEART MUSCLE CELL; IN VITRO STUDY; NONHUMAN; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

EID: 84857648398     PISSN: 00029629     EISSN: 15382990     Source Type: Journal    
DOI: 10.1097/MAJ.0b013e31822993ff     Document Type: Article

References (36)

1. Ruzicka M, Leenen FHH. Relevance of angiotensin II for cardiac hypertrophy and failure induced by cardiac volume overload. Heart Fail Rev 1999;3:169-81.
2. Domenighetti AA, Wang Q, Egger M, et al. Angiotensin II-mediated phenotypic cardiomyocyte remodeling leads to age-dependent cardiac dysfunction and failure. Hypertension 2005;46:426-32.
3. Sadoshima J, Izumo S. Molecular characterization of angiotensin II-induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts. Critical role of the AT1 receptor subtype. Circ Res 1993; 73:413-23.
4. Mazzolai L, Nussberger J, Aubert JF, et al. Blood pressure-independent cardiac hypertrophy induced by locally activated renin-angiotensin system. Hypertension 1998;31:1324-30.
5. Chien KR, Knowlton KU, Zhu H, et al. Regulation of cardiac gene expression during myocardial growth and hypertrophy: molecular studies of an adaptive physiologic response. FASEB J 1991;5:3037-46.
6. Liang F, Gardner DG. Autocrine/paracrine determinants of strainactivated brain natriuretic peptide gene expression in cultured cardiac myocytes. Biol Chem 1998;273:14612-9.
7. Lemmens K, Segers V, Demolder M, et al. Role of neuregulin-1/ ErbB2 signaling in endothelium-cardiomyocyte cross-talk. J Biol Chem 2006;281:19469-77.
8. Samal B, Sun Y, Steams G, et al. Cloning and characterization of the cDNA encoding a novel human pre-B-cell colony-enhancing factor. Mol Cell Biol 1994;14:1431-7.
9. Rongvaux A, Shea RJ, Mulks MH, et al. Pre-B-cell colony-enhancing factor, whose expression is up-regulated in activated lymphocytes, is a nicotinamide phosphoribosyltransferase, a cytosolic enzyme involved in NAD biosynthesis. Eur J Imruunol 2002;32:3225-34.
10. Fukuhara A, Matsuda M, Nishizawa M, et al. Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science 2005;307:426-30.
11. Mann DL. Inflammatory mediators and the failing heart: past, present, and the foreseeable future. Circ Res 2002;91:988-98.
12. Kukielka GL, Smith CW, LaRosa GJ, et al. Interleukin-8 gene induction in the myocardium after ischemia and reperfusion in vivo. J Clin Invest 1995;95:89-103.
13. Hattori Y, Akimoto K, Gross SS, et al. Angiotensin-II-induced oxidative stress elicits hypoadiponectinaemia in rats. Diabetologia 2005;48:1066-74.
14. Yamauchi T, Kamon J, Ito Y, et al. Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature 2003;423:762-9.
15. Purdham DM, Zou MX, Rajapurohitam V, et al. Rat heart is a site of leptin production and action. Am J Physiol Heart Circ Physiol 2004;287:2877-84.
16. Das DK, Mukherjee S, Ray D. Resveratrol and red wine, healthy heart and longevity. Heart Fail Rev 2010;15:467-77.
17. Dahl TB, Yndestad A, Skjelland M, et al. Increased expression of visfatin in macrophages of human unstable carotid and coronary atherosclerosis: possible role in inflammation and plaque destabilization. Circulation 2007;115:972-80.
18. Liu SW, Qiao SB, Yuan JS, et al. Association of plasma visfatin levels with inflammation, atherosclerosis and acute coronary syndromes (ACS) in humans. Clin Endocrinol (Oxf) 2009;71:202-7.
19. Kitani T, Okuno S, Fujisawa H. Growth phase-dependent changes in the subcellular localization of pre-B-cell colony-enhancing factor. FEBS Lett 2003;544:74-8.
20. Christian S, Andreia B, Joshua B, et al. Adipocyte dysfunction contributes to metabolic abnormalities in acute decompensated heart failure. Circulation 2007;116:708.
21. Bursac N, Parker KK, Iravanian S, et al. Cardiomyocyte cultures with controlled macroscopic anisotropy: a model for functional electrophysiological studies of cardiac muscle. Circ Res 2002;91:e45-54.
22. Lang MJ, Guo M, Zeng QT, et al. Effects of repeatedly differential attachment technique combined with 5-BrdU on the purity and the activity of isolated cardiomyocytes. Chin Heart J 2008;20:566-9.
23. Pedrotty DM, Klinger RY, Badie N, et al. Structural coupling of cardiomyocytes and noncardiomyocytes: quantitative comparisons using a novel micropatterned cell pair assay. Am J Physiol Heart Circ Physiol 2008;295:390-400.
24. Bae SK, Kim SB, Kim JG, et al. Hypoxic induction of human visfatin gene is directly mediated by hypoxia inducible factor-1. FEBS Lett 2006;580:4105-13.
25. Yang W, Luo YD, Wang FS, et al. Effects of taurine on the apoptosis of neonatal rat cardiomyocytes induced by angiotensin II. Acta Acad Med Jiangxi 2003;43:7-10.
26. Hsu CP, Oka S, Shao D, et al. Nicotinamide phosphoribosyltransferase regulates cell survival through NAD+ synthesis in cardiac myocytes. Circ Res 2009;105:481-91.
27. Greenland KJ, Mukhopadhyay AK. Selective activation of protein kinase C isoforms by angiotensin II in neuroblast oma X glioma cells. Mol Cell Endocrinol 2004;213:181-91.
28. Bumpus FM, Catt KJ, Chiu AZ, et al. Nomenclature for angiotensin receptors. A report of the Nomenclature Committee of the Council for High Blood Pressure Research. Hypertension 1991;17:720-1.
29. Matsubara H. Pathophysiological role of angiotensin-II type 2 receptor in cardiovascular and renal diseases. Circ Res 1998;83:1182-91.
30. Blais C, Leelair P, Molinaro G, et al. Absence of effect ofchronic a ngiotensin II type 1 receptor blockade on endogenous kinin concentrations in the carrageenan-induced paw edema model in the rat. Peptides 1999;20:343-52.
31. Kawano H, Do YS, Kawano Y, et al. Angiotensin II has multiple profibrotic effects in human cardiac fibroblasts. Circulation 2000;101: 1130-7.
32. Horiuchi M, Akishita M, Dzau VJ. Recent progress in angiotensin II type 2 receptor research in the cardiovascular system. Hypertension 1999;33:613-21.
33. Senbonmatsu T, Ichihara S, Price E Jr, et al. Evidence for angiotensin II type 2 receptor-mediated cardiac myocyte enlargement during in vivo pressure overload. J Clin Invest 2000;106:R25-9.
34. Kudoh S, Komuro I, Hiroi Y, et al. Mechanical stretch induces hypertrophic responses in cardiac myocytes of angiotensin II type l a receptor knockout mice. J Biol Chem 1998;273:24037-43.
35. Fishcr M, Liu B, Glennon PE, et al. Downregulation of the ERK 1 and 2 mitogen activated protein kinases using antisense oligonucleotides inhibits proliferation of porcine vascular smooth muscle ce1ls. Atherosclerosis 2001;156:289-95.
36. Booz GW, Dayj NE, Baker KM, et al. Interplay between the cardiac reninangiotensin system and JAK/STAT signaling: role in cardiac hypertrophy, ischemia/ reperfusion dysfunction and heart failure. J Mol Cell Cardiol 2002;34:1443-53.